FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture
FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

Your Health

Postmenopausal osteoporosis is a significant and women's health issue that far too often gets overlooked, despite being common. One in two women will experience a fracture due to osteoporosis in her lifetime, and these fractures can be devastating, with many leading to hospital stays and life-altering consequences.


A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

CLICK HERE To learn more about this new treatment option.

ADVERTISEMENT

What You Need to Know About Glaucoma: Q&A With Dr. Marlene R. Moster

What you can't see — the invisible disease that can leave you blind

Eye Conditions & Disorders

Your Corner Pharmacy – Joining the Front Lines of the Covid-19 Fight

Pharmacists will play a central role in the Biden administration's push to get America vaccinated against COVID-19

Prevention & Screenings

¿Necesita Ver a un Cardio-Oncólogo?

Los tratamientos que salvan vidas pueden aumentar el riesgo de enfermedades cardíacas. Un cardio-oncólogo puede ayudar a mantener su corazón sano mientras lucha contra el cáncer.

Created With Support